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Abstract
Background: Pycnodysostosis is a rare autosomal recessive skeletal dysplasia characterized by
short stature, osteosclerosis, acro-osteolysis, frequent fractures and skull deformities. Mutations
in the gene encoding cathepsin K (CTSK), a lysosomal cysteine protease, have been found to be
responsible for this disease.
Objectives: To identify pathogenic mutation in a consanguineous Pakistani family with 3 affected
individuals demonstrating autosomal recessive pycnodysostosis.
Methods: Genotyping of 10 members of the family, including three affected and seven unaffected
individuals was carried out by using polymorphic markers D1S442, D1S498, and D1S305, which are
closely linked to the CTSK gene on chromosome 1q21. To screen for mutations in the CTSK gene,
all of its exons and splice junctions were PCR amplified from genomic DNA and sequenced directly
in an ABI Prism 310 automated sequencer.
Results: Genotyping results showed linkage of the pycnodysostosis Pakistani family to the CTSK
locus. Sequence analysis of the CTSK gene revealed homozygosity for a missense mutation (A277V)
in the affected individuals.
Conclusion: We describe a missense mutation in the CTSK gene in a Pakistani family affected with
autosomal recessive pycnodysostosis. Our study strengthens the role of this particular mutation in
the pathogenesis of pycnodysostosis and suggests its prevalence in Pakistani patients.
Background
Pycnodysostosis is an uncommon autosomal recessive
skeletal dysplasia with a uniform clinical phenotype char-
acterized by short stature, osteosclerosis, acro-osteolysis
of the distal phalanges, frequent fractures, clavicular dys-
plasia and skull deformities with delayed suture closure.
Less than 200 patients have been reported worldwide
since the first description of the phenotype in 1962 [1].
The responsible gene was discovered by positional clon-
ing strategy as cathepsin K (CTSK) on chromosome 1q21
[2]. To date, 27 different mutations, spread throughout
the gene, have been reported in 34 unrelated pycnodysos-
tosis families [3,4]. CTSK gene encodes a polypeptide of
329 amino acids, a member of papain-cysteine protease
family and is highly expressed exclusively in osteoclasts
[5]. CTSK is critical for bone remodeling and resorption
by osteoclasts and therefore, it represents a potential tar-
get in treatment of diseases involving excessive bone loss
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such as osteoporosis. Cathepsin K-deficient mice gener-
ated by targeted inactivation of the CTSK gene display an
osteopetrotic phenotype, and their ultrastructural, histo-
logical, and radiological abnormalities closely resemble
those described for pycnodysostosis [6]. In the present
study, we report the identification of a missense mutation




We ascertained a Pakistani consanguineous family (Fig. 1)
including three individuals affected with pycnodysostosis.
The study was approved by the Institutional Review Board
of Quaid-i-Azam University Islamabad, Pakistan.
Informed consent was obtained from all family members
who participated in the study. Family pedigree provided
convincing evidence for autosomal recessive mode of
inheritance and consanguineous loops accounted for all
the affected persons being homozygous for the mutant
allele.
Extraction of genomic DNA and genotyping
Venous blood samples were obtained from 10 family
members, including the three affected individuals.
Genomic DNA was extracted from whole blood following
a standard protocol, quantified by spectrophotometric
measurement of optical density at 260 nm and diluted to
40 ng/μL for amplification by polymerase chain reaction
(PCR). PCR amplification of microsatellite markers
(D1S442, D1S498, and D1S305) was carried out accord-
ing to a standard procedure in a total volume of 25 μl,
containing: 40 ng genomic DNA, 20 pmol of each primer,
200 μM of each dNTP, 1 U of Taq DNA polymerase (MBI
Fermentas) and 1× PCR buffer. PCR was carried out for 35
cycles, with the following thermal cycling conditions:
95°C for one minute, 57°C for one minute, 72°C for one
minute, followed by final extension at 72°C for seven
minutes in a thermal cycler 9600 (Perkin Elmer, Norwalk,
Connecticut, USA). PCR products were resolved on 8%
non-denaturing polyacrylamide gel, along with the appro-
priate allelic ladder, and genotypes were assigned by vis-
ual inspection.
Pedigree of the individuals affected with Pycnodysostosis Figure 1
Pedigree of the individuals affected with Pycnodysostosis. Filled symbols identify affected subjects. Consanguineous 
marriages are represented with double lines. Haplotypes for the most closely linked markers are shown below each symbol.BMC Medical Genetics 2009, 10:76 http://www.biomedcentral.com/1471-2350/10/76
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Mutation analysis
PCR products of coding exons (2–8) and exon/intron
splice junctions of the CTSK gene were generated from
genomic DNA, purified with Rapid PCR Purification sys-
tem (Marligen Bio-sciences, Ijamsville, MD, USA) and
were sequenced in an ABI Prism 310 automated
sequencer, using the Big Dye Terminator Cycle Sequenc-
ing Kit (PE Applied Biosystems) following purification in
a Centri-Sep Spin Column (PE Applied Biosystems). The
primer sequences used are available on request. Sequence
variants were identified using Bioedit, sequence align-
ment editor version 6.0.7.
The identified mutation obliterated an AciI  site, so its
presence was assayed by PCR amplification of cathepsin K
exon 7 from genomic DNA, digestion of the product with
AciI, and separation of the resulting fragments by agarose
gel electrophoresis with direct visualization using ethid-
ium bromide.
Results
Clinical information was obtained for all family members
with the disease phenotype. All patients presented with
increased radiodensity of bones and skeletal dysplasia.
They had short stature, skull deformities with frontal
bossing, open sutures and fontanelles, dental malforma-
tions, hypoplasia of the mandible with obtuse mandibu-
lar angle and stubby hands and feet. The patients were
mentally normal and had no psychiatric illness. The age of
patient V-1 was 7 years at the time of study, while patients
V-5 and V-7 both were 11 years of age. Analysis of labora-
tory parameters showed normal values for Hb, leukocyte
number, thrombocyte number, MCV, plasma phosphate,
calcium and alkaline phosphatase. Heterozygous parents
were clinically indistinguishable from genotypically nor-
mal individuals.
Genotyping and mutation analysis
Genotyping of three affected and seven normal individu-
als from the family was performed with three polymor-
phic markers (D1S442, D1S498, and D1S305), closely
linked to CTSK locus on chromosome 1q21. The markers
were fully informative, and all the affected individuals of
the family were homozygous for the markers (Fig. 1), sug-
gesting linkage to the CTSK locus. The coding portion and
intron-exon borders of the CTSK  gene were then
sequenced. Sequence analysis in affected individuals (V-1,
V-5, V-7) revealed a homozygous C to T transition of
nucleotide 935 in exon 7 (Fig. 2c), predicting an alanine
to valine (A277V) amino acid substitution. This mutation
was present in the heterozygous state in obligate carriers
within the family (Fig. 2b). To ensure that the mutation
does not represent a neutral polymorphism in the Paki-
stani population, 50 normal individuals were screened for
mutation by direct sequencing and AciI restriction assay
(Fig. 3). The mutation was not identified outside the fam-
ily.
Discussion
Pycnodysostosis is a potentially life-threatening genetic
disease due to respiratory problems in early infancy. Mar-
oteaux and Lamy speculated that the French artist and
aristocrat Henri de Toulouse-Lautrec suffered from pycno-
dysostosis [1]. The gene encoding this phenotype has
been mapped to human chromosome 1q21 by genetic
linkage analysis, and the responsible gene was identified
by a positional cloning strategy, as cathepsin K, a lyso-
somal cysteine protease [2].
Mutation analysis of the CTSK gene Figure 2
Mutation analysis of the CTSK gene. DNA sequences of 
exon 7 of the CTSK gene from (a) a control individual, (b) a 
heterozygous carrier and (c) a homozygous (affected) indi-
vidual are shown. The arrow denotes nucleotide position 
935, which is mutated from C to T, resulting in A277V mis-
sense mutation.BMC Medical Genetics 2009, 10:76 http://www.biomedcentral.com/1471-2350/10/76
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This study presents identification of a missense mutation
(A277V) in the mature Cathepsin K polypeptide in a con-
sanguineous Pakistani family. The codon for alanine 277
in CTSK gene is GCG. The C to T transition at nucleotide
position 935 leading to A277V amino acid substitution
might be a result of methylated CpG deamination muta-
tion of 5-methyl cytosine. Methylated CpG sequences are
known to have a higher mutation rate than other dinucle-
otides [7]. In addition, there are two reports of an Ala to
Gln substitution by C to A transition at the same site [8],
suggesting that nt 935 is a mutational hotspot for pycno-
dysostosis. The A277V mutation has been previously
reported in 5 unrelated patients, two of whom are of Paki-
stani origin [3,8-10]. Identification of A277V mutation in
third Pakistani family suggests its prevalence in this pop-
ulation.
The A277 is highly conserved among papain family mem-
bers, existing as either an alanine or a glycine residue (Fig.
4). The 3D structure of cathepsin K have shown that A277
residue is located in the active site immediately next to the
invariably conserved H276 residue that forms the ion pair
with the active cysteine (C139) to affect protein catalysis
[11]. The expression studies [8] of A277V mutation
resulted in a precursor protein that was unable to autoac-
tivate and was unstable in the presence of pepsin. The
obliterative effects of A277V thus suggest that there is little
tolerance for larger amino acid side groups at this critical
position in the active cleft.
Conclusion
Identification of A277V mutation in Pakistani family
strengthens the role of this particular mutation in the
pathogenesis of pycnodysostosis and suggests its preva-
lence in Pakistani patients.
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An ethidium bromide-stained agarose gel containing 331-bp  amplified product that was digested with AciI Figure 3
An ethidium bromide-stained agarose gel containing 
331-bp amplified product that was digested with AciI. 
The digested PCR products from a normal control individual 
(N), an affected individual (P) and a heterozygous carrier (C) 
are shown. The normal PCR product was digested into 188-
bp and 143-bp fragments, whereas the 331-bp products with 
the A277V defect were not digested. A 100-bp DNA ladder 
is shown, left.
Alignment of conserved motif from the mature region of several members of the papain family of cysteine proteases and vari- ous species Figure 4
Alignment of conserved motif from the mature region of several members of the papain family of cysteine 
proteases and various species. The fourteen-residue motif from four human cysteine cathepsins (cathepsin K, cathepsin L, 
cathepsin S and cathepsin H) and cathepsin K of various species are aligned. The site of the cathepsin K A277V mutation is indi-
cated by the arrow. * indicates highly conserved amino acids while. and: indicate polar → polar and polar → non polar amino 
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